133 related articles for article (PubMed ID: 31694814)
21. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
He J; Fang W; Li ZG
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
[TBL] [Abstract][Full Text] [Related]
22. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
[TBL] [Abstract][Full Text] [Related]
23. The titers of antinuclear antibodies are associated with the degree of inflammation and organ damage in Primary Sjögren's Syndrome.
Shao H; Wu Y; Tao X; Liu Q; Ran C; Jin L; Tao J
Clin Exp Med; 2024 May; 24(1):96. PubMed ID: 38717644
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
25. Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.
Moutsopoulos HM; Zerva LV
Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):123-30. PubMed ID: 2203591
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against alpha-fodrin are associated with sicca syndrome in the general population.
Witte T; Matthias T; Bierwirth J; Schmidt RE
Ann N Y Acad Sci; 2007 Jun; 1108():414-7. PubMed ID: 17894005
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
Locht H; Pelck R; Manthorpe R
J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
[TBL] [Abstract][Full Text] [Related]
29. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
30. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.
Hernández-Molina G; Leal-Alegre G; Michel-Peregrina M
Autoimmun Rev; 2011 Jan; 10(3):123-5. PubMed ID: 20833272
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antibody assays for detection of autoantibodies to Ro 52, Ro 60 and La associated with primary Sjögren's syndrome.
Trier NH; Nielsen IØ; Friis T; Houen G; Theander E
J Immunol Methods; 2016 Jun; 433():44-50. PubMed ID: 26956184
[TBL] [Abstract][Full Text] [Related]
32. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
Miyawaki S
Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
[TBL] [Abstract][Full Text] [Related]
33. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
[TBL] [Abstract][Full Text] [Related]
34. Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis.
Li H; Zhang Y; Yi Z; Huang D; Wei S
PLoS One; 2014; 9(6):e99323. PubMed ID: 24950188
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?
Cinoku I; Mavragani CP; Tellis CC; Nezos A; Tselepis AD; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):61-67. PubMed ID: 30156537
[TBL] [Abstract][Full Text] [Related]
36. A prospective immunofluorescence study of immune deposits in the skin of primary Sjögren's syndrome.
Velthuis PJ; Nieboer C; Kater L; Hené RJ
Acta Derm Venereol; 1989; 69(6):487-91. PubMed ID: 2575320
[TBL] [Abstract][Full Text] [Related]
37. Serological and hematological characteristics of Sjogren's syndrome and dry eye syndrome patients using a novel immune serology technique.
Ben-Eli H; Solomon A; Aframian DJ; Ben-Chetrit E; Mevorach D; Kleinstern G; Waterboer T; Willhauck-Fleckenstein M; Pawlita M; Paltiel O
PLoS One; 2020; 15(12):e0244712. PubMed ID: 33382786
[TBL] [Abstract][Full Text] [Related]
38. Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants.
Routsias JG; Touloupi E; Dotsika E; Moulia A; Tsikaris V; Sakarellos C; Sakarellos-Daitsiotis M; Moutsopoulos HM; Tzioufas AG
Mol Med; 2002 Jun; 8(6):293-305. PubMed ID: 12428060
[TBL] [Abstract][Full Text] [Related]
39. Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens.
Blann AD; Wainwright AC; Emery P
Ann Rheum Dis; 1992 Mar; 51(3):389-90. PubMed ID: 1575588
[TBL] [Abstract][Full Text] [Related]
40. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
